Results 201 to 210 of about 642,036 (246)
Some of the next articles are maybe not open access.
INTRANASAL GONADOTROPIN-RELEASING HORMONE AGONIST AS A CONTRACEPTIVE AGENT
The Lancet, 1979The stimulatory luteinising hormone-releasing hormone (LRH) analogue D-Ser(TBU)6-EA10-LRH was administered intranasally once daily to twenty-seven regularly menstruating women to determine its efficacy as a contraceptive agent. Ovulation was inhibited during all but 2 of the 89 treatment months.
C, Bergquist, S J, Nillius, L, Wide
openaire +2 more sources
Gonadotropin-Releasing Hormone: Agonists and Antagonists
1997In adult women the cyclic function of the ovaries is embedded in the hypothalamic, pituitary, and ovarian feedback mechanisms [1]. The hypothalamus is the superordinate organ releasing gonadotropin-releasing hormone (GnRH) in a pulsatile manner. GnRH is secreted by the neural cells of the nucleus arcuatus in the mediobasal portion of the hypothalamus ...
R. Felberbaum, T. Rabe, K. Diedrich
openaire +1 more source
Gonadotropin-releasing hormone agonist use before hysterectomy
American Journal of Obstetrics and Gynecology, 1994Our purpose was to compare the effects of leuprolide acetate in patients with symptomatic uterine leiomyoma before hysterectomy.Group I (n = 90) included patients with a pretreatment uterine size of 14 to 18 gestational weeks and group II (n = 60) included patients with uteri > 18 weeks' gestational size.
T G, Stovall +3 more
openaire +2 more sources
Depressive symptoms associated with gonadotropin-releasing hormone agonists
Depression and Anxiety, 1998The gonadotropin-releasing hormone (GnRH) agonists are a relatively new class of drugs that are potentially effective in treating disorders that are aggravated either by estrogen or testosterone. GnRH agonists are effective in the treatment of endometriosis, as well as other disorders, such as advanced prostrate cancer, precocious puberty and uterine ...
J K, Warnock, J C, Bundren, D W, Morris
openaire +2 more sources
Journal of Animal Science, 1988
Sexually mature gilts (n = 20) were actively immunized against GnRH. Primary and booster immunizations of GnRH conjugated to bovine serum albumin induced production of antibodies in all gilts. Nineteen of the gilts became acyclic with suppressed concentrations of gonadotropins and estradiol.
G B, Traywick, K L, Esbenshade
openaire +2 more sources
Sexually mature gilts (n = 20) were actively immunized against GnRH. Primary and booster immunizations of GnRH conjugated to bovine serum albumin induced production of antibodies in all gilts. Nineteen of the gilts became acyclic with suppressed concentrations of gonadotropins and estradiol.
G B, Traywick, K L, Esbenshade
openaire +2 more sources
Effects of gonadotropin-releasing hormone agonists and antagonists on luteal function
Current Opinion in Obstetrics & Gynecology, 2007This review addresses the effects of gonadotropin-releasing hormone agonists and antagonists on various aspects of the luteal phase.Recent studies have shown that use of both gonadotropin-releasing hormone agonists and antagonists during in-vitro fertilization cycles leads to alterations in the hormonal profiles of the luteal phase as well as changes ...
Andrea J, DiLuigi, John C, Nulsen
openaire +2 more sources
Basic understanding of gonadotropin-releasing hormone–agonist triggering
Fertility and Sterility, 2015A single bolus of human chorionic gonadotropin (hCG) at midcycle has been the gold standard for triggering final oocyte maturation and ovulation in assisted reproductive technology cycles. More recently, gonadotropin-releasing hormone (GnRH)-agonist (GnRH-a) triggering has been introduced.
openaire +2 more sources
Journal of Neuroendocrinology, 1999
There exists evidence for the presence of ultrashort loop feedback circuits of gonadotropin‐releasing hormone (GnRH) secretion in the hypothalamus. It is, however, uncertain whether a similar mechanism is involved in the regulation of GnRH gene expression in vivo.
Y G, Han +5 more
openaire +2 more sources
There exists evidence for the presence of ultrashort loop feedback circuits of gonadotropin‐releasing hormone (GnRH) secretion in the hypothalamus. It is, however, uncertain whether a similar mechanism is involved in the regulation of GnRH gene expression in vivo.
Y G, Han +5 more
openaire +2 more sources
Gonadotropin-releasing hormone agonist (GnRH-A) in hirsutism.
Acta Europaea fertilitatis, 1995Twenty-five women presenting moderate-severe PCOS-dependant hirsuitism were treated for 6 months with GnRH-A (Group A) or pill-combined and GnRH (Group B). Both therapeutic regimens significantly decreased androgen plasma levels. Hair diameter reduced in Group A by 22-34% and in Group B by 25-35%, while hirsuitism score respectively decreased by 22 and
L, Falsetti, E, Pasinetti, D, Ceruti
openaire +2 more sources
Gonadotropin-Releasing Hormone Agonist Treatment in Sexual Precocity
2015Depot gonadotropin-releasing hormone (GnRH) analogs represent the first-line therapy in sexual precocity due to central precocious puberty. GnRH analogs desensitize the pituitary and account for the suppression of luteinizing hormone and follicle-stimulating hormone leading to a decrease of sex steroid levels.
Catherine, Pienkowski, Maithé, Tauber
openaire +2 more sources